Product Code: ETC066714 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
Australia infectious disease point of care testing market is experiencing significant growth due to the increasing adoption of rapid diagnostic tests for infectious diseases in healthcare settings. The demand for POC testing devices for quick and accurate diagnosis is driving market expansion.
The Australia Infectious Disease Point of Care Testing market is primarily driven by the demand for rapid diagnostic solutions in healthcare settings such as clinics, hospitals, and remote locations. With the need for timely diagnosis, patient management, and infection control, there is a rising requirement for point-of-care testing devices that offer simplicity, speed, and accuracy. Moreover, the expansion of telemedicine and the emphasis on decentralizing healthcare services further accelerate market growth, driving the adoption of infectious disease point-of-care testing products.
In the infectious disease point of care testing market, challenges include test accuracy, ease of use, and regulatory approval. Manufacturers must develop POC tests that offer rapid and reliable results for infectious diseases such as COVID-19, influenza, and HIV while ensuring user-friendliness and compliance with quality standards.
In regulating the infectious disease point of care testing market, government policies may aim to improve accessibility, affordability, and accuracy of diagnostic tests. Regulations may establish quality standards and performance criteria for point-of-care testing devices to ensure reliable results. Additionally, government initiatives may support the deployment of point-of-care testing in underserved areas and remote communities to enhance disease surveillance and outbreak response capabilities.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Infectious Disease Point-of-care Testing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Australia Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.6 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.7 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Australia Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of infectious diseases in Australia |
4.2.2 Growing awareness about the benefits of point-of-care testing for infectious diseases |
4.2.3 Technological advancements in point-of-care testing devices |
4.2.4 Government initiatives to improve healthcare infrastructure and accessibility |
4.2.5 Rising demand for rapid and accurate diagnostic solutions |
4.3 Market Restraints |
4.3.1 High cost associated with point-of-care testing devices |
4.3.2 Limited availability of skilled healthcare professionals for conducting tests |
4.3.3 Regulatory challenges and compliance requirements for point-of-care testing products |
4.3.4 Concerns regarding the accuracy and reliability of point-of-care testing compared to traditional laboratory testing methods |
4.3.5 Competition from alternative diagnostic methods and technologies |
5 Australia Infectious Disease Point-of-care Testing Market Trends |
6 Australia Infectious Disease Point-of-care Testing Market, By Types |
6.1 Australia Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2021-2031F |
6.1.3 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2021-2031F |
6.1.4 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2021-2031F |
6.1.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2021-2031F |
6.1.6 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2021-2031F |
6.1.7 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F |
6.2 Australia Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2021-2031F |
6.2.3 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2021-2031F |
6.2.4 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2021-2031F |
6.2.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2021-2031F |
6.3 Australia Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021-2031F |
6.3.3 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.4 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2021-2031F |
6.3.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F |
7 Australia Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Australia Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Australia Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Australia Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Adoption rate of point-of-care testing for infectious diseases in healthcare facilities |
8.2 Average turnaround time for obtaining test results using point-of-care testing devices |
8.3 Rate of reimbursement by healthcare payers for point-of-care testing services |
8.4 Number of research and development initiatives focused on enhancing point-of-care testing technologies |
8.5 Percentage of healthcare providers offering point-of-care testing services for infectious diseases |
9 Australia Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Australia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.2 Australia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2021 & 2031F |
9.3 Australia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Australia Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Australia Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2024 |
10.2 Australia Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |